Envelaf 37.5mg Tablet XR
By Envelaf
Rx
10 Tablet XR in a Strip

Composition
Venlafaxine(37.5mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
September, 2026

liver
When using Envelaf 37.5mg Tablet XR, it is important to exercise caution if you have a liver disease. In such cases, dose adjustment of Envelaf 37.5mg Tablet XR may be necessary for your safety. It is advisable to seek guidance from your doctor regarding the use of this medication to ensure it is suitable for your liver condition.

kidney
Envelaf 37.5mg Tablet XR requires caution in patients with kidney disease. Dose adjustment might be necessary. Consult your doctor for guidance.

alcohol
**Safety Advice - Alcohol** Avoid consuming alcohol while taking Envelaf 37.5mg Tablet XR as it is considered unsafe to do so.

driving
Caution while driving Envelaf 37.5mg Tablet XR may cause dizziness, confusion, and blurred vision, affecting your driving ability.

pregnancy
Envelaf 37.5mg Tablet XR may not be safe to use during pregnancy. Limited human studies indicate potential harm to the baby. Your doctor will assess risks versus benefits before prescribing. Please consult your doctor.

breastfeeding
During breastfeeding, using Envelaf 37.5mg Tablet XR is likely unsafe. Limited human data indicates it may pass into breastmilk and harm the baby. Monitor babies for excessive sleepiness, and ensure they are gaining weight adequately.
| Habit Forming | No |
| Chemical Class | Anisole Derivative |
| Therapeutic Class | NEURO CNS |
| Action Class | Serotonin-norepinephrine reuptake inhibitors (SNRIs) |
₹23.8
₹28
15% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
